Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
intoxication par le tamoxifène d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Formestane poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Accidental formestane poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Intentional formestane poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
intoxication par le formestane d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Vinca alkaloid poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Vinblastine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Accidental vinblastine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Intentional vinblastine poisoning (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
intoxication par la vinblastine d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Vincristine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Accidental vincristine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Intentional vincristine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
intoxication par la vincristine d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Vindesine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Accidental vindesine poisoning (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Intentional vindesine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
intoxication par la vindésine d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Immunosuppressant poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
1 |
Cyclosporin poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Accidental cyclosporin poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Intentional cyclosporin poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Immunosuppressant adverse reaction |
Causative agent (attribute) |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
1 |
Cyclosporin adverse reaction |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Immunosuppressant allergy |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Allergy to ciclosporin (finding) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Immunosuppressant overdose |
Causative agent (attribute) |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
1 |
Cyclosporin overdose (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Accidental cyclosporin overdose |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Intentional cyclosporin overdose |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporin overdose of undetermined intent |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by thiotepa |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
abciximab 2 mg/mL, fiole de 5 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by fluorouracil |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
palivuzimab 50 mg, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Drugs used in malignant disease and for immunosuppression |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cytotoxic immunosuppressants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing antilymphocyte immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rituximab 10mg/mL injection concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rituximab 10mg/mL infusion concentrate 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing antibody, immunoglobulin M class |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
HA-1A |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Equine anti-human thymocyte immunoglobulin 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Equine gamma globulin 10mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Mouse monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing rabbit anti-human T-lymphocyte globulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rabbit anti-human T-lymphocyte globulin 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Abciximab 10mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 250mg/amp |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 100mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Palivizumab 100mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 250mg/5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 100mg/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 25mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 100mg gel capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Cyclosporine 50mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rituximab 500mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rituximab 100mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing gemtuzumab ozogamicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Tacrolimus (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Mycophenolate mofetil (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Sirolimus (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing anakinra (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Anakinra 100mg/0.67mL injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning caused by antineoplastic antibiotic |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by bleomycin |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by cactinomycin |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing lymphocyte immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
médicament immunosuppresseur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by cyclophosphamide |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing ciclosporin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by mercaptopurine |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Poisoning by chlorambucil |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Ciclosporin |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Alefacept (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Palivizumab 100mg powder for injection 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing tositumomab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing omalizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Product containing efalizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Raptiva |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Efalizumab 125mg/vial lyophilized powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Raptiva 125mg/vial lyophilized powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Anakinra 100mg injection solution 0.67mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Mycophenolic acid (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Gemtuzumab ozogamicin |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Omalizumab (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Efalizumab (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rituximab (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Antilymphocyte immunoglobulin (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Rabbit anti-human T-lymphocyte globulin (substance) |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Selective adhesion molecule inhibitor |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Calcineurin inhibitor |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Muromonab-CD3 |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan (substance) |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Macrolide immunosuppressant |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
[X]Immunosuppressive agents causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|
Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Some |
|